Recombinant factor VIIa (rFVIIa) has been used to treat bleeding complications in patients with hemophilia. It acts at the site of vessel injury, forming a complex with tissue factor to activate the clotting cascade. Recent reports have shown rFVIIa may be a useful hemostatic agent in patients after obstetrical, urologic, trauma, or transplant procedures. We report the first documented case of bleeding from hemorrhage pancreatitis treated with rFVIIa.
Get full access to this article
View all access options for this article.
References
1.
HednerU. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis1998;9(suppl l):S147–52.
2.
RapaportSI, RaoLV. The tissue factor pathway: How it has become a “prima ballerina.”Thromb Haemost1995;74:7–17.
3.
MannKG. Biochemistry and physiology of blood coagulation. Thromb Haemost1999;82:165–74.
4.
MonroeDM, HoffmanM, OliverJA, . A possible mechanism of action of factor VIIa independent of tissue factor. Blood Coagul Fibrinolysis1998;9:S15–20.
5.
FriederichPW, WeverPC, BrietE, . Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease. Am J Hematol2001;66:294–94.
6.
KristensenJ, KillanderA, HippeE, . Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis1996;26(suppl 1):159–64.
7.
PetersM, HeijboerH. Treatment of patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost1998;80:352.
8.
HednerU. NovoSeven® as a universal hemostatic agent. Blood Coagul Fibrinolysis2000;11:107–11.
9.
deWolffJT, HendriksHG, MeijerK, . Impressive reduction of blood requirements in orthotopic liver transplantation due to recombinant factor VIIa (RFVIIa, Novoseven). Transfusion1999;39:87S.
10.
WhiteB, McHaleJ, RaviN. Successful use of recombinant FVIIa in the management of post-surgical intra-abdominal hemorrhage. Br J Haematol1999;107:677–78.
11.
KenetG, WaldenR, EldadA, . Treatment of traumatic bleeding with recombinant factor VIIa. Lancet1999;354:1879.
12.
O'NeillPA, BluthN, GlosterE, . Successful use of recombinant factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma2002;52:400–5.
13.
FriederichPW, HenryCP, MesselinkEJ, . Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet2003;361:201–5.
